Join the club for FREE to access the whole archive and other member benefits.

Bit.bio

Human cell coding company

Bit.bio is an award-winning synthetic biology enterprise, coding human cells for health. The company's aim is to develop a platform capable of producing consistent batches of every human cell. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.

Visit website: https://bit.bio/

 bitbioltd

 bitbio

Details last updated 12-Apr-2021

People at Bit.bio

Mark Kotter

Neurosurgeon, stem cell biologist and founder of bit.bio

Bit.bio News

Bit.bio reveals early pipeline of regenerative medicine candidates

Endpoints News - 08-Nov-2023

Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025

Read more...

Synthetic human cells revolution: bit.bio achieves mass production breakthrough

iNews - 15-Jun-2023

Paves way for potential medical research, organ manufacturing and disease treatment advances

Read more...

Bit Bio secures $41.5 M funding to produce human cells

Biospace - 15-Jun-2020

UK-based startup reprogramming stem cells to generate new cell therapies

Read more...
Topics mentioned on this page:
Synthetic Biology